Idiopatic Lobular Panniculitis as a common clinical problem


Cite item

Full Text

Abstract

Aim. To present clinical and laboratory characteristics of various forms of idiopatic lobular panniculitis (ILP) in modern rheumatology practice. Materials and methods. The study included 67 people (58 women and 9 men aged 20 to 76) with the referral diagnosis of "Erythema nodosa? Undifferentiated panniculitis?" in 76.2% of cases with a median disease duration of 78.91 [48; 540] months observed in the V.A. Nasonova Research Institute of Rheumatology. In 2007-2017 in addition to general clinical examination immunological, histological and immunohistochemical studies, computed tomography (CT) of the chest organs and tuberculin tests were performed. Results. Analysis of clinical manifestations allowed to distinguish four forms of ILP: nodular (n=30), plaque (n=10), infiltrative (n=15) and mesentric (n=12). The minimum median duration of the disease was detected in plaque form (8 [5; 11.5] months), while the median duration in case of infitrative form was 8.25 times longer (66 [36; 102] months, p<0.001). As a result of the meta - analysis, the typical prognostic factors for various ILP forms were identified: nodular - multiple symmetrical nodes; plaque - fever >38 °C and a small number (up to 5) of drain nodes; infiltrative - fever >38 °C, ulceration of nodes with the expiration of oily mass and scarring; mesenteric - pain in the abdominal area, the number of nodes less than 5 and the abdominal cavity CT results (inflammation of the adiopose tissue of the intestinal mesentery, omentum, adipose tissue of the pre - and retroperitoneal areas). Conclusion. The forms and activity of the disease determine the approaches to treatment in modern clinical practice. There is an obvious need to expand knowledge about this pathology among doctors and conduct further research in order to timely diagnose and search for the most effective methods of ILP treatment.

About the authors

O N Egorova

V.A. Nasonova Scientific and Research Institute of Rheumatology

Email: onegorova@yandex.ru
с.н.с. лаб. изучения роли инфекций при ревматических заболеваниях ФГБНУ «НИИР им. В.А. Насоновой»; ORCID: 0000-0002-4846-5531 Moscow, Russia

B S Belov

V.A. Nasonova Scientific and Research Institute of Rheumatology

д.м.н., зав. лаб. изучения роли инфекций при ревматических заболеваниях ФГБНУ «НИИР им. В.А. Насоновой»; ORCID: 0000-0001-7091-2054 Moscow, Russia

S I Glukhova

V.A. Nasonova Scientific and Research Institute of Rheumatology

к.ф.-м.н. учебно-методического отд. с центром информационных технологий ФГБНУ «НИИР им. В.А. Насоновой»; ORCID: 0000-0002-4285-0869 Moscow, Russia

S G Radenska-Lopovok

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)

д.м.н., проф., проф. каф. патологической анатомии им. А.И. Струкова ФГБОУ ВО «Первый МГМУ им. И.М. Сеченова»; ORCID: 0000-0002-4669-260X Moscow, Russia

References

  1. Requena L, Yus E.S. Panniculitis. Part I. Mostly septal panniculitis. J Am Acad Dermatol. 2001;45(2):163-83. https://doi.org/10.1067/ mjd.2001.114736
  2. Requena L, Sanchez Yus E. Panniculitis. Part II. Mostly lobular panniculitis. J Am Acad Dermatol. 2001;45(3):325-61. https://doi.org/10.1067/mjd.2001.1147 35
  3. Ter Poorten M.C, Thiers B.H. Panniculitis. Dermatol Clin. 2002;20(3):421-33. https://doi.org/10.1016/S0733-8635(02)00008-6
  4. Wick M.R. Panniculitis: а summary. Semin Diagn Pathol. 2017;34(3):261-72. doi: 10.1053/j.semdp.2016.12.004
  5. Вербенко Е.В., Беленький Г.Б. К клинико - морфологической характеристике болезни Вебера-Крисчена. Вестник дерматологии и венерологии. 1971;2:14-9.
  6. Diaz Cascajo C, Borghi S, Weyers W. Panniculitis: definition of terms and diagnostic strategy. Am J Dermat. 2000;22:530-49.
  7. Mavrikakis I, Georgiadis T, Fragiadaki K, Sfikakis P.P. Orbital lobular panniculitis in Weber-Christian disease: sustained response to anti-TNF treatmentand review of the literature. Survey Оphthalmol. 2010;55(6):584-9. doi: 10.1016/j.survophthal.2010.05.001
  8. Hinata M, Someya T, Yoshizaki H, et al. Successful treatment of steroidresistant Weber-Christian disease with biliary ductopenia using cyclosporin A. Rheumatol. 2005;44(6):821-3. doi: 10.1093/ rheumatology/keh576
  9. Iwasaki T, Hamano T, Ogata A, et al. Successful treatment of a patient with febrile, lobular panniculitis (Weber-Christian disease) with oral cyclosporin A: implications for pathogenesis and therapy. Intern Med. 1999;38(7):612-61. PMID: 10435371
  10. Вербенко Е.В. Спонтанный панникулит. В кн.: Кожные и венерические болезни. Руководство для врачей. Под ред. Ю.К. Скрипкина. М.: Медицина, 1995;2:399-410.
  11. Ахмеров С.Ф., Нуриахметова Т.Ю., Абдракипов Р.З. и др. Длительное наблюдение пациентки с панникулитом Вебера-Крисчена. Современная ревматология. 2017;11(2):57-9. https://doi.org/10.14412/1996-7012-2017-2-57-59
  12. Белоглазов В.А., Петров А.В., Шадуро Д.В. и др. Панникулит Крисчена-Вебера (разбор клинического случая). Крымский терапевтический журнал. 2014;2:154-7.
  13. Metha R, Gahlot G.P, Das P, et al. Sclerosing mesenteric panniculitis in a young patient : common cause of diagnostic dilemma and treatment refractoriness. Acta Gastroenterol Belg. 2016;79(2):254-6.
  14. Le Corguillé M, Lévy P, Nahon S, et al. Weber-Christian syndrome due to pancreaticomesenteric fistula secondary to acute alcoholic pancreatitis: treatment with pancreatic sphincterotomy alone. Gastroenterol Clin Biol. 2003;27(6-7): 660-2. PMID: 12910236
  15. Егорова О.Н., Белов Б.С., Раденска-Лоповок С.Г. и др. Дифференциальная диагностика панникулитов. Врач. 2014;11:14-9.
  16. Муразян Р.И., Панченков Н.Р. Экстренная помощь при ожогах. М.: Медицина, 1983:63-64.
  17. Егорова О.Н., Белов Б.С., Глухова С.И., Раденска-Лоповок С.Г. Идиопатический лобулярный панникулит: оценка активности (собственные данные). Медсовет. 2018;1:130-5. doi: 10.21518/2079-701X-2018-1-130-13

Copyright (c) 2019 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies